Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2015 (2015), Article ID 864545, 4 pages
http://dx.doi.org/10.1155/2015/864545
Case Report

Fatal Case of Probable Invasive Aspergillosis after Five Years of Heart Transplant: A Case Report and Review of the Literature

1Department of Internal Medicine, CHI Health Creighton University School of Medicine, 601 North 30th Street No. 5850, Omaha, NE 68131, USA
2Medical School, Creighton University School of Medicine, Omaha, NE, USA
3Division of Infectious Diseases, CHI Health Creighton University School of Medicine, Omaha, NE, USA

Received 18 May 2015; Accepted 11 August 2015

Academic Editor: Oguz R. Sipahi

Copyright © 2015 Toufik Mahfood Haddad et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. L. Hibberd and R. H. Rubin, “Clinical aspects of fungal infection in organ transplant recipients,” Clinical Infectious Diseases, vol. 19, supplement 1, pp. S33–S40, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kousha, R. Tadi, and A. O. Soubani, “Pulmonary aspergillosis: a clinical review,” European Respiratory Review, vol. 20, no. 121, pp. 156–174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. B. H. Segal and T. J. Walsh, “Current approaches to diagnosis and treatment of invasive aspergillosis,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 7, pp. 707–717, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. G. Montoya, L. F. Giraldo, B. Efron et al., “Infectious complications among 620 consecutive heart transplant patients at stanford university medical center,” Clinical Infectious Diseases, vol. 33, no. 5, pp. 629–640, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. I. J. Sánchez-Lázaro, L. Almenar, M. Blanes et al., “Timing, etiology, and location of first infection in first year after heart transplantation,” Transplantation Proceedings, vol. 42, no. 8, pp. 3017–3019, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. P. G. Pappas, B. D. Alexander, D. R. Andes et al., “Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET),” Clinical Infectious Diseases, vol. 50, no. 8, pp. 1101–1111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Haddad, T. Deuse, M. Pham et al., “Changing trends in infectious disease in heart transplantation,” Journal of Heart and Lung Transplantation, vol. 29, no. 3, pp. 306–315, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Muñoz, I. Cerón, M. Valerio et al., “Invasive aspergillosis among heart transplant recipients: a 24-year perspective,” Journal of Heart and Lung Transplantation, vol. 33, no. 3, pp. 278–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Sambatakou, B. Dupont, H. Lode, and D. W. Denning, “Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis,” American Journal of Medicine, vol. 119, no. 6, pp. 527.e17–527.e24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Gavalda, O. Len, R. San Juan et al., “Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study,” Clinical Infectious Diseases, vol. 41, no. 1, pp. 52–59, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. Shields, M. H. Nguyen, M. A. Shullo et al., “Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome,” Scandinavian Journal of Infectious Diseases, vol. 44, no. 12, pp. 982–986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. G. Montoya, S. V. Chaparro, D. Celis et al., “Invasive aspergillosis in the setting of cardiac transplantation,” Clinical Infectious Diseases, vol. 37, supplement 3, pp. S281–S292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. E. G. Playford, A. C. Webster, T. C. Sorell, and J. C. Craig, “Antifungal agents for preventing fungal infections in solid organ transplant recipients,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD004291, 2004. View at Google Scholar
  14. N. Singh, “Antifungal prophylaxis for solid organ transplant recipients: seeking clarity amidst controversy,” Clinical Infectious Diseases, vol. 31, no. 2, pp. 545–553, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Muñoz, M. Valerio, J. Palomo et al., “Targeted antifungal prophylaxis in heart transplant recipients,” Transplantation, vol. 96, no. 7, pp. 664–669, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. B. De Pauw, T. J. Walsh, J. P. Donnelly et al., “Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group,” Clinical Infectious Diseases:, vol. 46, no. 12, pp. 1813–1821, 2008. View at Google Scholar
  17. W. Meersseman, K. Lagrou, J. Maertens et al., “Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 1, pp. 27–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. K. A. Marr, “Empirical antifungal therapy—new options, new tradeoffs,” The New England Journal of Medicine, vol. 346, no. 4, pp. 278–280, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Oyake, S. Kowata, K. Murai et al., “Comparison of micafungin and voriconazole as empirical antifungal therapies in febrile neutropenic patients with hematological disorders: a randomized controlled trial,” European Journal of Haematology, 2015. View at Publisher · View at Google Scholar
  20. K. A. Marr, H. T. Schlamm, R. Herbrecht et al., “Combination antifungal therapy for invasive aspergillosis: a randomized trial,” Annals of Internal Medicine, vol. 162, no. 2, pp. 81–89, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. J. A. Vazquez, “Combination antifungal therapy for mold infections: much ado about nothing?” Clinical Infectious Diseases, vol. 46, no. 12, pp. 1889–1901, 2008. View at Publisher · View at Google Scholar · View at Scopus